We compare measured output factors of clinical electron fields to those calculated by a commercial treatment planning system based on an electron Monte Carlo algorithm. The measured data is comprised of 195 fields with energies 6 to 18 MeV, applicator sizes 6 × 6 cm 2 to 25 × 25 cm 2 , and source to surface distances (SSDs) of 97 to 107 cm. Due to a scarcity of clinical fields for the highest energies and the largest applicator sizes, additional measurements were made at arbitrarily chosen large field sizes at previously not used energies, for a total of 223 output factors. The difference between calculation and measurement ranged from -2.9% to 3.9%, with a mean difference of -0.2%. Half of the field shapes had a difference with magnitude less than 0.8%. Only 7 (3%) of the field shapes were outliers, having differences greater than 2%. All outliers had field widths at the normalization point < 3.5 cm, were applied at SSDs > 100 cm, were inserts for the 25 × 25 cm 2 applicator, or had more than one of these characteristics. For narrow and elongated fields the TPS slightly overestimated output factors, whereas for field shapes with aspect ratio close to 1 the TPS slightly underestimated the output factors. No strong dependence of the difference on energy was observed.
Introduction
Monte Carlo techniques have been used in radiotherapy for many years (1-4), but only on a limited scale due to the long computational time required for acceptable statistical uncertainty. To expedite computations, approximations based on precalculated electron fields have been suggested (5-7). Recently, the macro Monte Carlo (MMC) method of Neuenschwander et al. has been implemented by Varian Medical Systems (Palo Alto, CA) in their Eclipse electron Monte Carlo (eMC) treatment planning system. Relative dose distributions provided by this system have been evaluated (8, 9) . Absolute dose calculations have been reported by Ding et al. (8) for a wide range of square and rectangular field shapes at 100 cm to 120 cm SSD. We also reported absolute doses for standard applicator field sizes, as well as for a 3 cm circular, 4 cm square, and a triangular field at 100 cm SSD (9). A recent investigation by Hu et al. (10) compared measured to calculated output factors, PDDs, penumbra and other beam parameters for four accelerators of the same manufacturer and model. Many combinations of square fields, electron cones and energies were tested, and agreement between measurement and calculation was considered acceptable for cutout sizes not smaller than 5 × 5 cm 2 . Nevertheless, concerns remain in clinical applications when electron Technology in Cancer Research & Treatment, Volume 8, Number 4, August 2009 fields are small or substantially deviate from simple geometric figures like circles, squares and rectangles. To test the Varian eMC algorithm for the irregular fields typical in the clinic, we computed output factors of cutouts that had been previously used on patients and compared them with measurements.
Materials and Methods
The output factor of an electron cutout is defined in the report of American Association of Physicists in Medicine Radiation Therapy Committee Task Group No. 25 (TG-25) (11) as the ratio between the dose delivered by the cutout at its depth of maximum dose to the dose delivered by a reference electron cone at its respective depth of maximum dose. In the past, we have measured output factors for all cutouts that substantially reduced the area of the standard electron cones, and kept them in a library together with a tracing of each cutout, and the energy and SSD at which it was used. Measurements were made in water, water equivalent plastic and polystyrene, using a PTW model 23333 Farmer chamber, a PTW model N31010 cylindrical chamber, or a PTW model 23343 Markus chamber. Measurements for which the depth was different from the reference depth were corrected for the stopping power ratio, as described Zhang et al. (12) Output factors for new patients were taken from the library if a matching field could be found, otherwise additional measurements were done. At the time of this writing, 195 field sizes had been measured for the dosimetrically equivalent Clinac 21EX, iX and 2100CD linear accelerators (Varian Medical Systems, Palo Alto, CA). For this work, we supplemented our existing library with 28 field shape/energy combinations, obtained by re-measuring existing cutouts at different energies, to assure that each applicator/ energy combination encompassed at least four fields. The distribution of field energies and applicator sizes is shown in Table I , while the distribution of SSDs is shown in Table II .
Calculations were done using the Varian eMC version 8.0.05, which was part of the Eclipse treatment planning system (TPS) version 7.5. The field shapes from the library were fed into the computer using a standard digitizer tablet. The eMC has five user selected parameters: calculation grid size, calculation accuracy, maximum number of particle histories, smoothing, and random number generator seed. We examined the effect of calculation grid size, calculation accuracy, and smoothing on relative dose distributions in a previous work. (10) Based on that work, we chose a grid size of 1 mm for 6 and 9 MeV, whereas 1.5 mm, 2 mm, and 2.5 mm were used for 12, 15, and 18 MeV, respectively. All calculations were done using the maximum calculation accuracy, 1%, which prompts the eMC to simulate particles until in the high dose region this level of variance is achieved. Our earlier work also demonstrated that the agreement for relative dose distributions is improved by smoothing. Unless otherwise stated, we used in this work 3D smoothing with a Gaussian kernel of standard deviation equal to 1.5 times the grid spacing (the Varian eMC refers to this as "strong smoothing"). To forestall potential bias, we used a different, randomly chosen seed in the random number generator for each calculation.
We performed calculations for two data sets. First, after commissioning the eMC, we verified that it correctly reproduced the output factors of the standard applicators which were part of the commissioning data. For each energy and applicator combination, eight separate calculations were done and statistically analyzed. The mean of these calculations was considered the computed output factor, while the standard deviation between calculations and the limits on the 95% confidence level were used as indicators of computational precision. Agreement with measurement was an indicator of accuracy.
For each of the 195 patient-specific cutouts and the 28 additional clinical cutouts, only one output factor calculation was done and compared to the corresponding measurement. Differences between the output factors of cutouts used at the same energy and applicator size were statistically analyzed as a group. To estimate the experimental uncertainty, we remeasured the output factors of ten cutouts.
To allow comparison of output factors of irregular clinical fields as a function of field shape, we calculated the major and minor axes (a and b, respectively) of the equivalent ellipse, i.e., the ellipse with the same normalized second central moments as each field shape, and used the ratio b/a as a measure of field elongation. An example of the approximation of an irregular field by the equivalent ellipse is shown in Figure 1 . The dependence of computational accuracy on electron energy E was studied by a scatter plot of difference between computation and measurement as a function of b/E.
Gaussian smoothing is a form of weighted volume averaging, causing doses near the point of interest to contribute to the dose reported at the point of interest. In areas of constant dose, smoothing improves precision by providing better dose statistics without affecting accuracy. In areas of high gradient, however, averaging can lead to systematic errors due to the inclusion of neighboring points where the dose may be higher or lower. To investigate the effect of smoothing on our results, we computed the output factor for the a narrow cutout, 2.6 cm x 22 cm, at 9 MeV (field #113 in our database, shown in Figure 2 ) and a standard 4 × 4 cm 2 cutout six times using smoothing, and compared the results to unsmoothed data.The eMC output factor calculations are obtained from point doses, whereas the measurements are made over a finite volume. For narrow fields, the dose is peaked such that there is curvature of the distribution across the ionization chamber volume. The dose measured by the ionization chamber is approximately the average of the dose across the chamber volume and the measured output factor for a narrow field will therefore be smaller than the "true" output factor obtained from a point dose. We tested the validity of comparing volume averaged doses, with point doses, in the following way. For field # 113 and the 4 × 4 cm 2 standard insert, the eMC calculated dose was integrated over a 0.125 cm 3 sphere centered at d max to approximate the conditions of measurement with the 0.125 cm 3 PTW model N31010 cylindrical chamber. We then compared output factors derived from point doses and volume averaged doses. Field # 113 was chosen because it was very narrow and exhibited the largest difference between computed and measured output factors.
Results

Output Factors of Standard Applicators
Table III shows a comparison between calculated and measured output factors for all standard applicator/energy combinations. The first entry is the difference between the mean of the eight computations and measurement. The second entry is the standard deviation of the eight individual computations, whereas the third entry (in parentheses) indicates the limits on the 95% confidence interval of the computed mean. Figure 3 shows a scatter plot of eMC-calculated versus measured output factors for the clinical field shapes. Figure 4 is a histogram of number of fields vs. difference between calculation and measurement. For all clinical cutouts and SSDs, these differences ranged between -2.9% and 3.9%. Only 7 (3%) of the field shapes exhibited a difference of magnitude greater than 2%, while half of the field shapes agreed with measurement to better than 0.8%. A statistical analysis of differences is shown in Table IV . The mean value of differences for all cutouts was -0.3% at a 95% confidence interval of 0.1%. The variance of the distribution of differences was ± 1.0%. Figure 5 is a scatter plot of the difference vs. SSD. For the 27 field shapes with SSD 100 cm the mean difference was -0.6% at a 95% confidence interval of 0.3%. The dependence of differences on field elongation, field width and b/E ratio is shown in Figures 6, 7 and 8, respectively.
Output Factors of Clinical Cutouts
Volume Averaging and Smoothing
The effects of volume averaging and Gaussian smoothing on output factors are summarized in Tables V and VI. In each table, the second column shows six eMC simulations of output factors at d max , calculated with different seeds Table III Comparison between eMC-calculated and measured output factors for standard applicators. The values represent, respectively, the mean difference between calculation and measurement, the 95% confidence interval on the mean difference and (in parentheses) the standard deviation of the distribution.
Energy
Applicator A04* A06 A10 A15 A20 A25 All
*Standard A06 applicator with factory-supplied 4 cm × 4 cm 2 insert.
in the random number generator, and no smoothing. The third column lists the output factors obtained from the same calculations, but with averaging over a 0.125 cm 3 spherical volume. Columns 4 and 5 apply to strong smoothing of point doses and 0.125 cm 3 volume averaged doses, respectively.
Experimental Uncertainty
Following the procedure outlined in the previous section, the uncertainty in measurement of the output factor was established as ± 0.5%.
Discussion
The observed statistical fluctuation of unsmoothed doses (Tables V and VI) is smaller than the 1% statistical precision for the high dose region, defined as the region with dose > 50% of maximum, set for the calculation. This effect is likely due to the better dose statistics at d max than elsewhere in the high dose region. Smoothing, which was applied for the data in Tables III and IV, further reduces statistical uncertainty, leading to the relatively small 0.4% standard deviation for all factory-supplied applicators.
Agreement between computed and measured output factors is quite good, and compares favorably with the current accuracy of IMRT photon dose calculations. Combining all clinical cutouts and energies suggests a 0.3% systematic underestimation by the eMC compared to measurements. For the standard square fields, the underestimation amounts to 0.7%. The largest discrepancy encountered was 3.9% for a very narrow and highly elongated cutout. Since discrepancies for many cutouts exceeded the 0.5% experimental error of measurements and the expected statistical fluctuations inherent to MC calculations, some systematic errors or shortcomings in the eMC may be present.
Dose averaging over the active volume of the ion chamber and smoothing cannot explain the discrepancies. Volume averaging reduces the measured output factors by 0.7% for the 2.6 cm wide field # 113, and by 0.5% for the wider 4 × 4 cm 2 applicator where dose gradients near d max are smaller. Tables V and VI show that smoothing reduces the output factor computed for the field # 113 by 0.8%, and for the slightly wider 4 × 4 cm 2 applicator by 0.4%. It is noteworthy that the volume averaging and smoothing errors are almost equal and tend to cancel one another when comparing measurements and computations.
A final source of error is the potential breakdown of the algorithm under certain conditions. The scatter plot of dose difference ( Figure 4 ) suggests a slightly more pronounced underestimation at SSDs 100 cm compared to SSD = 100 cm. Figure 7 suggests that output factors of cutouts narrower than about 4 cm tend to be overestimated, whereas the opposite is true for cutouts wider than 7 cm. Nevertheless, the absolute error for 97% of cutouts was less than 2%, in compliance with the output factor constancy for electron applicators recommended by the AAPM TG 40 Report (13). Four of the seven outliers (defined as having discrepancies > 2%) had widths 3.5cm, two were applied at SSDs > 100 cm, and one was an insert for the large 25 × 25 cm 2 applicator.
There have been several studies of the Monte Carlo calculation of output factors for electron fields using the EGS4/BEAM code. (14-16) Those studies, like ours, found that in most cases the calculated output factors agreed with measurement to within 2%, but that deviations of up to 4% were noted. One study (15) pointed out that most of the variations larger than 2% were for small, elongated fields. Similarly, in our study four of the seven field shapes with differences greater than 2% are highly elongated ( Figure 6 ). However, a significant number of field shapes with difference less than 2% also occupy this region, suggesting that field elongation is not a reliable predictor of computational accuracy.
It is recognized that field size has the most significant effect on output factor when the smallest dimension is less than that required for lateral scatter equilibrium. (17) A measure of the distance from the beam edge required to obtain lateral scatter equilibrium is the practical range R p , given approximately by E/2 in centimeters of water where E is the electron energy in MeV. Lateral scatter equilibrium is obtained at the center of a field when the smallest field dimension is 2R p . Figure 8 shows a scatter plot of the difference as a function of the ratio of minor axis length to energy, b/E, which is approximately b/2R p . This plot suggests that there is a systematic difference between narrow and wide fields. The mean difference for b/E < 1 is 0.1%, with a 95% confidence interval of 0.1%, and a standard deviation of 1.0%. For b/E 1 the mean difference is -1.2%, with a 95% confidence interval of 0.2%, and a standard deviation of 0.6%. The result for b/E 1 is consistent with the standard applicator values, for which the mean difference was -0.7%. On average, the accuracy of the eMC appears to be slightly better for elongated fields, although the largest deviations were also encountered in elongated fields, suggesting that for narrow fields the eMC is slightly more accurate but less precise.
Conclusion
The Varian macro Monte Carlo based electron treatment planning system calculates output factors for the majority of clinical field shapes to within 2%. Such accuracy meets the requirements for output factor constancy of electron applicators as specified by the Report of the AAPM Report Task Group 40. The strong Gaussian smoothing option should be used to reduce errors caused by statistical fluctuations. As with any dosimetric calculation, it is recommended to use comparisons with tabulated data or measurements to confirm the computer generated data. Examination of the 3D dose distribution can also help to detect errors. Special caution is recommended for field widths < 3.5 cm, SSDs 100 cm and cutouts for the 25 × 25 cm 2 applicator. Under these conditions the eMC algorithm may be less accurate.
